Prospective cost analysis from the provider's perspective: pharmaco-economic results from AGO-WSG intergroup adjuvant EC→DOC trial vs. CMF in nodal-positive breast cancer and its reimbursement : San Antonio breast cancer symposium
In: CANCER RESEARCH 69(2):6111-6111; Jg. 69 (2009) 2, S. 6111-6111
Konferenz
Zugriff:
Titel: |
Prospective cost analysis from the provider's perspective: pharmaco-economic results from AGO-WSG intergroup adjuvant EC→DOC trial vs. CMF in nodal-positive breast cancer and its reimbursement : San Antonio breast cancer symposium
|
---|---|
Autor/in / Beteiligte Person: | Jacobs, V.R. ; Braun, M. ; Harbeck, N. ; Wagenpfeil, S. ; Sattler, D. ; Bernard, R. ; Kuhn, W. ; Nitz, U. ; Ihbe-Heffinger, A. |
Link: | |
Quelle: | CANCER RESEARCH 69(2):6111-6111; Jg. 69 (2009) 2, S. 6111-6111 |
Veröffentlichung: | 2009 |
Medientyp: | Konferenz |
Sonstiges: |
|